CLINICAL TRIALS & RESEARCH
Resources

Public Comments submitted: “Draft Guidance, Key Information and Facilitating Understanding in Informed Consent”

Public Comments

Comments provided on: April 30, 2024

Comments provided to: U.S. Food and Drug Administration